🇺🇸 Continuation of boosted PI in United States

Continuation of boosted PI (Continuation of boosted PI) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Continuation of boosted PI in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Continuation of boosted PI approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Continuation of boosted PI in United States?

Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic is the originator. The local marketing authorisation holder may differ — check the official source linked above.